| Year |
Citation |
Score |
| 2024 |
Tonetto S, Weikop P, Thomsen M. Nutritional ketosis as treatment for alcohol withdrawal symptoms in female C57BL/6J mice. Scientific Reports. 14: 5092. PMID 38429369 DOI: 10.1038/s41598-024-55310-3 |
0.323 |
|
| 2023 |
Tonetto S, Weikop P, Brudek T, Thomsen M. Behavioral and biochemical effects of alcohol withdrawal in female C3H/HeNRj and C57BL/6JRj mice. Frontiers in Behavioral Neuroscience. 17: 1143720. PMID 36910126 DOI: 10.3389/fnbeh.2023.1143720 |
0.601 |
|
| 2022 |
Molander A, Thorbek DD, Lysne C, Weikop P, Fink-Jensen A, Wörtwein G. Inactivation of the cholinergic M receptor results in a disinhibited endophenotype predicting alcohol use. Behavioural Brain Research. 430: 113921. PMID 35533894 DOI: 10.1016/j.bbr.2022.113921 |
0.447 |
|
| 2020 |
Weikop P, Jensen KL, Thomsen M. Effects of muscarinic M receptor stimulation on reinforcing and neurochemical effects of cocaine in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32344426 DOI: 10.1038/S41386-020-0684-1 |
0.653 |
|
| 2018 |
Runegaard AH, Sørensen AT, Fitzpatrick CM, Jørgensen SH, Petersen AV, Hansen NW, Weikop P, Andreasen JT, Mikkelsen JD, Perrier JF, Woldbye D, Rickhag M, Wortwein G, Gether U. Locomotor- and Reward-Enhancing Effects of Cocaine Are Differentially Regulated by Chemogenetic Stimulation of Gi-Signaling in Dopaminergic Neurons. Eneuro. 5. PMID 29938215 DOI: 10.1523/ENEURO.0345-17.2018 |
0.368 |
|
| 2018 |
Jensen KL, Sørensen G, Dencker D, Owens WA, Rahbek-Clemmensen T, Brett Lever M, Runegaard AH, Riis Christensen N, Weikop P, Wörtwein G, Fink-Jensen A, Madsen KL, Daws L, Gether U, Rickhag M. PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis. Eneuro. 5. PMID 29911172 DOI: 10.1523/ENEURO.0422-17.2018 |
0.404 |
|
| 2017 |
Dencker D, Molander A, Thomsen M, Schlumberger C, Wortwein G, Weikop P, Benveniste H, Volkow ND, Fink-Jensen A. Ketogenic Diet suppresses Alcohol Withdrawal Syndrome in Rats. Alcoholism, Clinical and Experimental Research. PMID 29160944 DOI: 10.1111/Acer.13560 |
0.594 |
|
| 2017 |
Thomsen M, Dencker D, Wortwein G, Weikop P, Egecioglu E, Jerlhag E, Fink-Jensen A, Molander A. The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice. Pharmacology, Biochemistry, and Behavior. PMID 28778739 DOI: 10.1016/J.Pbb.2017.07.014 |
0.627 |
|
| 2017 |
Dall C, Weikop P, Dencker D, Molander AC, Wörtwein G, Conn PJ, Fink-Jensen A, Thomsen M. Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine. Drug and Alcohol Dependence. 176: 154-161. PMID 28544993 DOI: 10.1016/J.Drugalcdep.2017.03.014 |
0.643 |
|
| 2016 |
Møller LL, Sylow L, Gøtzsche CR, Serup AK, Christiansen SH, Weikop P, Kiens B, Woldbye DP, Richter EA. Decreased spontaneous activity in AMPK α2 muscle specific kinase dead mice is not caused by changes in brain dopamine metabolism. Physiology & Behavior. 164: 300-5. PMID 27306083 DOI: 10.1016/j.physbeh.2016.06.010 |
0.326 |
|
| 2015 |
Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiology & Behavior. 149: 262-8. PMID 26072178 DOI: 10.1016/J.Physbeh.2015.06.013 |
0.46 |
|
| 2015 |
de la Cour C, Sørensen G, Wortwein G, Weikop P, Dencker D, Fink-Jensen A, Molander A. Enhanced self-administration of alcohol in muscarinic acetylcholine M4 receptor knockout mice. European Journal of Pharmacology. 746: 1-5. PMID 25445043 DOI: 10.1016/J.Ejphar.2014.10.050 |
0.463 |
|
| 2012 |
Dencker D, Weikop P, Sørensen G, Woldbye DPD, Wörtwein G, Wess J, Fink-Jensen A. An allosteric enhancer of M4 muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine Psychopharmacology. 224: 277-287. PMID 22648127 DOI: 10.1007/S00213-012-2751-8 |
0.48 |
|
| 2012 |
Dencker D, Thomsen M, Wörtwein G, Weikop P, Cui Y, Jeon J, Wess J, Fink-Jensen A. Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease. Acs Chemical Neuroscience. 3: 80-89. PMID 22389751 DOI: 10.1021/Cn200110Q |
0.636 |
|
| 2012 |
Sørensen G, Jensen M, Weikop P, Dencker D, Christiansen SH, Loland CJ, Bengtsen CH, Petersen JH, Fink-Jensen A, Wörtwein G, Woldbye DP. Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice. Psychopharmacology. 222: 565-77. PMID 22367168 DOI: 10.1007/S00213-012-2651-Y |
0.435 |
|
| 2011 |
Dencker D, Wörtwein G, Weikop P, Jeon J, Thomsen M, Sager TN, Mørk A, Woldbye DPD, Wess J, Fink-Jensen A. Involvement of a subpopulation of neuronal M 4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M 1/M 4 preferring muscarinic receptor agonist xanomeline Journal of Neuroscience. 31: 5905-5908. PMID 21508215 DOI: 10.1523/Jneurosci.0370-11.2011 |
0.634 |
|
| 2011 |
Schmidt LS, Thomsen M, Weikop P, Dencker D, Wess J, Woldbye DPD, Wortwein G, Fink-Jensen A. Increased cocaine self-administration in M 4 muscarinic acetylcholine receptor knockout mice Psychopharmacology. 216: 367-378. PMID 21373792 DOI: 10.1007/S00213-011-2225-4 |
0.669 |
|
| 2007 |
Hansen HH, Andreasen JT, Weikop P, Mirza N, Scheel-Krüger J, Mikkelsen JD. The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine. European Journal of Pharmacology. 570: 77-88. PMID 17628530 DOI: 10.1016/j.ejphar.2007.05.029 |
0.338 |
|
| Show low-probability matches. |